Which renal transplant patients should receive cytomegalovirus immune globulin? A cost-effectiveness analysis

Joel Tsevat, David R. Snydman, Stephen G. Packer, Isabelle Durand-Zaleski, Barbara G. Werner, Andrew S. Levey

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'Which renal transplant patients should receive cytomegalovirus immune globulin? A cost-effectiveness analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences